CAI — Caris Life Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2019410 ·
Last close
$19.94
Market Cap
$5.72B
52W High
$36.50
52W Low
$14.19
ADV30
4,020,144
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 275,358,000 | 182,285,000 | 19,316,000 | 15,250,000 | 1,255,623,000 | 665,321,000 | 616,142,000 |
| Jun 2026 | 263,712,000 | 179,596,000 | 26,926,000 | -637,000 | 1,229,620,000 | 690,915,000 | 637,886,000 |
| Mar 2026 | 216,174,000 | 141,348,000 | 5,282,000 | -510,000 | 1,162,388,000 | 821,147,000 | 568,898,000 |
| Dec 2025 | 292,886,000 | 220,914,000 | 88,411,000 | 81,957,000 | 1,125,663,000 | 796,274,000 | 548,356,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$168,558,000
Investing CF
$-144,719,000
Financing CF
$-53,777,000
CapEx
$-44,602,000
Dividends Paid
—
Buybacks
$-21,452,000
EPS Diluted TTM
$0.36
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,549,883,000
Inventory
$123,791,000
Receivables
$116,888,000
ST Investments
$102,200,000
EBIT TTM
$151,924,000
Pretax Income TTM
$105,024,000
Interest Exp TTM
$46,900,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,048,129,024
EBITDA
$162,435,008
Free Cash Flow
$-25,855,876
Enterprise Value
$6,931,212,800
Total Cash
$767,379,968
Total Debt
$463,020,000
Shares Out
286,784,504
Trailing EPS
$1.66
Book Value
$2.23
ROE
17.2%
ROA
7.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 812,033,000 | 45,113,000 | -68,088,000 | 1,125,663,000 | 548,356,000 | 577,307,000 | 83,155,000 |
| Dec 2024 | 412,260,000 | -257,122,000 | -281,890,000 | 343,734,000 | 2,842,572,000 | -2,498,838,000 | -245,199,000 |
| Dec 2023 | 306,128,000 | -319,551,000 | -341,415,000 | 412,900,000 | 2,557,850,000 | -2,144,950,000 | -276,100,000 |
| Dec 2022 | 258,485,000 | -315,756,000 | -320,827,000 | 717,422,000 | 2,419,535,000 | -1,702,113,000 | -285,706,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$1,229,620,000
Forward EPS
$0.36
Max Pain — expiry 2027-01-15
max pain strike: $30.00 · spot: $19.50 · call oi: 3,200 · put oi: 3,317
Expected Move to 2027-01-15:
±$4.60
(23.59%) —
implied range
$14.90 –
$24.10
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RDNT | RadNet, Inc. | $5.90B | $74.92 | — |
| LFST | LifeStance Health Group, Inc. | $5.39B | $14.17 | — |
| CON | Concentra Group Holdings Parent, Inc. | $5.36B | $42.38 | — |
| GRAL | GRAIL, Inc. | $4.76B | $105.88 | — |
| OPCH | Option Care Health, Inc. | $4.74B | $31.63 | — |
News headlines (Yahoo Finance, 1h cache)
Genomic Data Set for RWE Applications - Global Strategic Business Report 2026: Capitalize on 16% CAGR and $1.5B in Total Revenue by 2032 with Illumina, Caris Life Sciences and Datavant
2026-11-18 15:38 · Yahoo
Caris Life Sciences Presented Research Demonstrating the Value of Whole Transcriptome Sequencing in Precision Oncology at the Association of Molecular Pathology 2026 Annual Meeting
2026-11-16 13:30 · Yahoo
Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer
2026-11-09 13:30 · Yahoo
Caris Life Sciences Inc (CAI) Q3 2026 Earnings Call Highlights: Record Revenue, Sixth Straight ...
2026-11-07 13:04 · Yahoo
Caris Life (CAI) Q3 2026 Earnings Call Transcript
2026-11-05 15:45 · Yahoo
14% Below Fair Value? Caris Life Sciences (CAI) On Raised 2026 Guidance
2026-11-05 09:13 · Yahoo
Caris Life Sciences Q3 Earnings Call Highlights
2026-11-05 01:14 · Yahoo
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-11-04 21:05 · Yahoo
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
2026-10-19 10:30 · Yahoo
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
2026-10-15 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.